“DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020016. doi:10.4084/mjhid.2020.016.